Efficacy of perioperative inhalational oxytocin on postoperative pain in lower limb fracture surgeries

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202406682157896

Enrollment

Registered

2024-06-28

Start date

2024-06-20

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases

Interventions

oxytocine group

intravenous morphine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age from 18 to 45 years old. 2. ASA of class I and II. 3. Both sexes.

Exclusion criteria

Exclusion criteria: 1. Patient refusal. 2. Uncontrolled Psychiatric diseases. 3. Known intolerance to the study drugs. 4. Unstable cardiovascular condition.

Design outcomes

Primary

Measure	Time frame
Total postoperative morphine requirement in the 1 st 72 hours postoperative.	—

Secondary

Measure	Time frame
1. Time to the first request of morphine rescue analgesia. 2. visual analogue scale score 2, 4, 6, 12, 24, 48, 72 hours postoperative. 3. Perioperative hemodyamics (MAP - HR). 4. Postoperative side effect as nausa, vomiting.	—

Countries

Egypt

Contacts

Public ContactKarim Awad

lecturer of anesthesia and surgical icu

Dr.karimali2010@mans.edu.eg+201004209702

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026